BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.
Rihawi K, Giannarelli D, Galetta D, Delmonte A, Giavarra M, Turci D, Garassino M, Tiseo M, Barbieri F, Panni S, Ardizzoni A.
Rihawi K, et al. Among authors: ardizzoni a.
J Thorac Oncol. 2019 Mar;14(3):e57-e59. doi: 10.1016/j.jtho.2018.11.036.
J Thorac Oncol. 2019.
PMID: 30782386
Free article.
No abstract available.